Further studies are required to investigate the mechanism by which CD206+ M2-like macrophages regulate the browning phenomenon, which has the potential to become an effective therapeutic tool for the prevention and treatment of insulin resistance and obesity. The gene discussed is MRC1; the disease is obesity due to melanocortin 4 receptor deficiency.